DE60319093D1 - Verfahren zur isolierung eines intestilanen cholesterin bindenproteins - Google Patents

Verfahren zur isolierung eines intestilanen cholesterin bindenproteins

Info

Publication number
DE60319093D1
DE60319093D1 DE60319093T DE60319093T DE60319093D1 DE 60319093 D1 DE60319093 D1 DE 60319093D1 DE 60319093 T DE60319093 T DE 60319093T DE 60319093 T DE60319093 T DE 60319093T DE 60319093 D1 DE60319093 D1 DE 60319093D1
Authority
DE
Germany
Prior art keywords
isolating
intestilane
cholesterin
bind protein
bind
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60319093T
Other languages
English (en)
Other versions
DE60319093T2 (de
Inventor
Werner Kramer
Wendelin Frick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Sanofi Aventis Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland GmbH filed Critical Sanofi Aventis Deutschland GmbH
Application granted granted Critical
Publication of DE60319093D1 publication Critical patent/DE60319093D1/de
Publication of DE60319093T2 publication Critical patent/DE60319093T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60319093T 2002-08-06 2003-07-28 Verfahren zur isolierung eines intestilanen cholesterin bindenproteins Expired - Lifetime DE60319093T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02017504 2002-08-06
EP02017504 2002-08-06
PCT/EP2003/008290 WO2004014947A1 (en) 2002-08-06 2003-07-28 Method for isolating an intestinal cholesterol binding protein

Publications (2)

Publication Number Publication Date
DE60319093D1 true DE60319093D1 (de) 2008-03-27
DE60319093T2 DE60319093T2 (de) 2009-02-05

Family

ID=31502689

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60319093T Expired - Lifetime DE60319093T2 (de) 2002-08-06 2003-07-28 Verfahren zur isolierung eines intestilanen cholesterin bindenproteins

Country Status (17)

Country Link
US (2) US7435727B2 (de)
EP (1) EP1529061B1 (de)
JP (1) JP4575772B2 (de)
KR (1) KR101095288B1 (de)
CN (1) CN1330667C (de)
AT (1) ATE386053T1 (de)
AU (1) AU2003253341C1 (de)
BR (1) BR0313217A (de)
CA (1) CA2493487C (de)
DE (1) DE60319093T2 (de)
HK (1) HK1082509A1 (de)
IL (2) IL166492A (de)
MX (1) MXPA05001264A (de)
NO (2) NO333437B1 (de)
RU (1) RU2345089C2 (de)
WO (1) WO2004014947A1 (de)
ZA (1) ZA200500053B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
US7135556B2 (en) 2002-07-19 2006-11-14 Schering Corporation NPC1L1 (NPC3) and methods of use thereof
AU2004303742B2 (en) 2003-12-23 2008-06-19 Astrazeneca Ab Diphenylazetidinone derivatives possessing cholesterol absorption inhibitory activity
EP1723414A4 (de) 2004-01-16 2008-03-26 Merck & Co Inc Npc1l1 (npc3) und verfahren zur identifizierung seiner liganden
CN101243072A (zh) 2005-06-20 2008-08-13 先灵公司 用作组胺h3拮抗剂的哌啶衍生物
SA06270191B1 (ar) 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
WO2007100807A2 (en) 2006-02-24 2007-09-07 Schering Corporation Npc1l1 orthologues
AR060623A1 (es) 2006-04-27 2008-07-02 Astrazeneca Ab Compuestos derivados de 2-azetidinona y un metodo de preparacion
CN1869704B (zh) * 2006-06-14 2010-06-30 厦门大学 快速鉴定与病原菌互作的宿主蛋白的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710469A (en) * 1986-05-02 1987-12-01 Merck & Co., Inc. Novel phosphotyrosyl protein phosphatase
CA2002607C (en) 1988-11-10 2004-01-27 Gordon G. Wong Natural killer stimulatory factor
ES2168091T3 (es) * 1990-05-16 2002-06-01 Genetics Inst Proteinas de induccion osea y cartilaginosa.
US5264372A (en) 1991-03-15 1993-11-23 Amylin Pharmaceuticals, Inc. Receptor-based screening methods for amylin agonists and antagonists
US5518911A (en) 1995-01-06 1996-05-21 Onyx Pharmaceuticals, Inc. Human PAK65
JP3088681B2 (ja) 1997-05-22 2000-09-18 宮城県 形質膜局在シアリダーゼ及びそれをコードするｄｎａ
US6383734B1 (en) 1998-09-30 2002-05-07 Advanced Research And Technology Institute, Inc. Method to determine inhibition of PAK3 activation of Raf-1
JP2000166545A (ja) * 1998-12-07 2000-06-20 Snow Brand Milk Prod Co Ltd 胆汁酸活性化リパーゼ
AU3566200A (en) 1999-04-01 2000-10-23 Astrazeneca Uk Limited Human signal transduction serine/threonine protein kinase
AU4343500A (en) * 1999-04-16 2000-11-02 Schering Corporation Use of azetidinone compounds
DE10042447A1 (de) * 2000-08-29 2002-03-28 Aventis Pharma Gmbh Protein aus dem Darm von Wirbeltieren, welches Cholesterin absorbiert, sowie Verwendung dieses Proteins zur Identifizierung von Inhibitoren des intestinalen Cholesterintransports

Also Published As

Publication number Publication date
CN1330667C (zh) 2007-08-08
DE60319093T2 (de) 2009-02-05
BR0313217A (pt) 2005-06-14
US7435727B2 (en) 2008-10-14
AU2003253341C1 (en) 2009-09-24
US20080167451A1 (en) 2008-07-10
ZA200500053B (en) 2006-07-26
JP4575772B2 (ja) 2010-11-04
NO333437B1 (no) 2013-06-03
IL166492A0 (en) 2006-01-15
CA2493487C (en) 2013-01-22
JP2006512054A (ja) 2006-04-13
US20040126812A1 (en) 2004-07-01
RU2345089C2 (ru) 2009-01-27
US7786103B2 (en) 2010-08-31
AU2003253341A1 (en) 2004-02-25
ATE386053T1 (de) 2008-03-15
RU2005106238A (ru) 2005-08-27
WO2004014947A1 (en) 2004-02-19
CA2493487A1 (en) 2004-02-19
KR101095288B1 (ko) 2011-12-16
KR20060015443A (ko) 2006-02-17
IL199409A (en) 2010-12-30
EP1529061B1 (de) 2008-02-13
CN1668642A (zh) 2005-09-14
EP1529061A1 (de) 2005-05-11
AU2003253341B2 (en) 2009-04-23
HK1082509A1 (en) 2006-06-09
IL166492A (en) 2010-12-30
MXPA05001264A (es) 2005-04-28
NO20051169L (no) 2005-05-02
NO20130115L (no) 2005-05-02

Similar Documents

Publication Publication Date Title
ATE449186T1 (de) Zusammensetzungen und verfahren zur selektiven nukleinsäureisolierung
NO20051169L (no) Fremgangsmate for a isolere et intestinalt kolesterolbindende protein
DE602005015426D1 (de) System und Verfahren zur Intensivierung von Audiosignalen
DE602005004354D1 (de) Verfahren zur Lokalisierung von Fluoreszenzmarkers
DE60326012D1 (de) Verfahren zur Konzentration von Proteinen
DE60313283D1 (de) Verfahren zur zusammenfassung von unbekanntem videoinhalt
ATE362530T1 (de) Verfahren und vorrichtung zur reinigung von nukleinsäuren
DE602004002618D1 (de) Verfahren und System zur Kantenhervorhebung
DE602005007219D1 (de) Verfahren und Vorrichtung zur Trennung von Schallquellensignalen
DE60335733D1 (de) Verfahren zur solubilisierung von protein
DE502005007752D1 (de) Verfahren zur robotergestützten vermessung von messobjekten
DE112004001806D2 (de) Verfahren zur Selbstjustierenden Verkleinerung von Strukturen
ATE336175T1 (de) Verfahren zur geruchsneutralisation von sojaprotein-zusatzstoffe
DE60308234D1 (de) Schmierungssystem und Verfahren zur Modifizierung
DE60336713D1 (de) Verfahren zur nassbehandlung von scheibenförmigen gegenständen
DE602004022042D1 (de) Verfahren und kit zur identifizierung antibiotikaresistenter mikroorganismen
DE602005021766D1 (de) Verfahren zur behandlung von atherosklerose
ATA4522002A (de) Verfahren zur erkennung von geisterfahrern
DE60301283D1 (de) Verfahren zur Bestimmung von Biopolymeren
IL173506A0 (en) Method for the purification of a non-immunoglobulin protein comprising an immunoglobulin-like (ig-like) domain
DE50301044D1 (de) Verfahren zur auswahl von transpondern
DE10393421D2 (de) Verfahren zur Anreicherung und zum Nachweis von pathologisch veränderten Prion-Proteinen (PRPSC)
DE60327307D1 (de) Verfahren zur abschätzung von bodenreaktion von zweibeinigen beweglichen körpern
ATA14432002A (de) Verbessertes verfahren zur singlet sauerstoff oxidation von organischen substraten
DE50203864D1 (de) Verfahren zur Unterdrückung von Jammer-Signalen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition